Latticework
← Viking Global Investors

Viking Global Investors's 2024Q2 portfolio

Viking Global Investors (Viking Global Investors) held 27 positions as of Jun 30, 2024, with the largest position at 6.9% of the portfolio.

Showing positions still held at the most recent quarter so their historical weights can be reconstructed. Positions that were held in 2024Q2but have since been exited aren't included in this table — for a full point-in-time reconstruction, use the SEC EDGAR filing directly.

Holdings as of Jun 30, 2024 (27)

  1. 1AMZNAmazon.com Inc
    % port
    6.9%
    +2.3pp vs prior Qnow 0.7%
  2. 2MSFTMicrosoft Corp
    % port
    3.9%
    +1.4pp vs prior Qnow 2.4%
  3. 3APGApi Group Corp
    % port
    3.9%
    -0.3pp vs prior Qnow 0.7%
  4. 4AAPLApple Inc
    % port
    3.7%
    +1.2pp vs prior Qnow 2.6%
  5. 5PGRProgressive Corp
    % port
    3.2%
    +0.9pp vs prior Qnow 0.9%
  6. 6FTVFortive Corp
    % port
    2.9%
    -0.2pp vs prior Qnow 3.5%
  7. 7(cusip)Roivant Sciences Ltd
    % port
    2.8%
    now 0.5%
  8. 8BBIOBridgebio Pharma Inc
    % port
    2.4%
    -0.4pp vs prior Q
  9. 9JPMJpmorgan Chase & CO
    % port
    2.3%
    now 2.2%
  10. 10BMRNBiomarin Pharmaceutical Inc
    % port
    2.2%
    +0.1pp vs prior Qnow 1.1%
  11. 11MCDMcdonald's Corp
    % port
    1.8%
    now 3.2%
  12. 12TMUST-mobile US Inc
    % port
    1.7%
    -1.0pp vs prior Q
  13. 13CPTCamden Property Trust
    % port
    1.4%
    +1.0pp vs prior Q
  14. 14HCAHca Healthcare Inc
    % port
    0.8%
    +0.2pp vs prior Qnow 1.4%
  15. 15CSXCsx Corp
    % port
    0.6%
    now 2.1%
  16. 16NAMSNewamsterdam Pharma Company
    % port
    0.6%
    -0.1pp vs prior Qnow 0.4%
  17. 17RRXRegal Rexnord Corp
    % port
    0.6%
    now 1.6%
  18. 18METAMeta Platforms Inc-class A
    % port
    0.5%
    -0.8pp vs prior Qnow 1.7%
  19. 19SHWSherwin-williams Co/the
    % port
    0.5%
    now 2.8%
  20. 20ADPTAdaptive Biotechnologies
    % port
    0.4%
    now 1.2%
  21. 21LABStandard Biotools Inc
    % port
    0.4%
    -0.2pp vs prior Qnow 0.2%
  22. 22CVNACarvana CO
    % port
    0.3%
    now 2.4%
  23. 23(cusip)Pharvaris N V
    % port
    0.3%
  24. 24ORICOric Pharmaceuticals Inc
    % port
    0.1%
  25. 25INBXInhibrx Biosciences Inc
    % port
    0.1%
    now 0.3%
  26. 26PEPGPepgen Inc
    % port
    0.1%
  27. 27TRVITrevi Therapeutics Inc
    % port
    0.1%

13F-HR filings disclose long US-equity positions only. 13Fs don't cover shorts, bonds, derivatives, or non-US listings, so the picture here is the public part of the portfolio — not the whole.

Not investment advice.